LIAN
Income statement / Annual
Last year (2022), LianBio's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, LianBio's net income was -$110.29 M.
See LianBio,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.00 M
|
$525,696.00
|
$76,130.00
|
$0.00
|
| Gross Profit |
-$1.00 M
|
-$525,696.00
|
-$76,130.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$59.76 M
|
$158.69 M
|
$120.89 M
|
$22.66 M
|
| General & Administrative Expenses |
$65.60 M
|
$36.88 M
|
$13.98 M
|
$4,111.20
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$1.71 M
|
| Selling, General & Administrative Expenses |
$65.60 M
|
$36.88 M
|
$13.98 M
|
$1.72 M
|
| Other Expenses |
$0.00
|
-$455,000.00
|
$123,000.00
|
$0.00
|
| Operating Expenses |
$124.20 M
|
$195.57 M
|
$134.87 M
|
$24.38 M
|
| Cost And Expenses |
$125.20 M
|
$195.57 M
|
$134.87 M
|
$24.38 M
|
| Interest Income |
$0.00
|
$243,322.00
|
$4,854.00
|
$11,018.00
|
| Interest Expense |
$0.00
|
$243,000.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.01 M
|
$525,000.00
|
$76,000.00
|
$171,860.00
|
| EBITDA |
-$124.35 M |
-$195.05 M |
-$134.79 M |
-$24.38 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$14.73 M
|
-$212,000.00
|
-$4.73 M
|
$10,018.00
|
| Income Before Tax |
-$110.62 M
|
-$195.78 M
|
-$139.60 M
|
-$24.37 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$332,604.00
|
$518,000.00
|
$4,000.00
|
$4,006.89
|
| Net Income |
-$110.29 M
|
-$196.30 M
|
-$139.60 M
|
-$24.37 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
| EPS |
-1.02 |
-5.71 |
-1.33 |
-0.23 |
| EPS Diluted |
-1.02 |
-5.71 |
-1.33 |
-0.23 |
| Weighted Average Shares Out |
$107.92 M
|
$34.39 M
|
$105.26 M
|
$108.30 M
|
| Weighted Average Shares Out Diluted |
$107.92 M
|
$34.39 M
|
$105.26 M
|
$108.30 M
|
| Link |
|
|
|
|
